JP2023521149A5 - - Google Patents
Info
- Publication number
- JP2023521149A5 JP2023521149A5 JP2022561644A JP2022561644A JP2023521149A5 JP 2023521149 A5 JP2023521149 A5 JP 2023521149A5 JP 2022561644 A JP2022561644 A JP 2022561644A JP 2022561644 A JP2022561644 A JP 2022561644A JP 2023521149 A5 JP2023521149 A5 JP 2023521149A5
- Authority
- JP
- Japan
- Prior art keywords
- vector
- sequence
- adenovirus
- gene
- cell line
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025159003A JP2025175172A (ja) | 2020-04-07 | 2025-09-25 | 生産のためのアデノウイルス発現ベクター及び方法並びに細胞株 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063006266P | 2020-04-07 | 2020-04-07 | |
| US63/006,266 | 2020-04-07 | ||
| PCT/US2021/025890 WO2021207136A1 (en) | 2020-04-07 | 2021-04-06 | Adenoviral expression vector and methods and cell lines for production |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025159003A Division JP2025175172A (ja) | 2020-04-07 | 2025-09-25 | 生産のためのアデノウイルス発現ベクター及び方法並びに細胞株 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023521149A JP2023521149A (ja) | 2023-05-23 |
| JP2023521149A5 true JP2023521149A5 (enExample) | 2024-03-29 |
| JP7750858B2 JP7750858B2 (ja) | 2025-10-07 |
Family
ID=75660398
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022561644A Active JP7750858B2 (ja) | 2020-04-07 | 2021-04-06 | 生産のためのアデノウイルス発現ベクター及び方法並びに細胞株 |
| JP2025159003A Pending JP2025175172A (ja) | 2020-04-07 | 2025-09-25 | 生産のためのアデノウイルス発現ベクター及び方法並びに細胞株 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025159003A Pending JP2025175172A (ja) | 2020-04-07 | 2025-09-25 | 生産のためのアデノウイルス発現ベクター及び方法並びに細胞株 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US12227754B2 (enExample) |
| EP (1) | EP4133090A1 (enExample) |
| JP (2) | JP7750858B2 (enExample) |
| KR (1) | KR20230008069A (enExample) |
| CN (2) | CN122104807A (enExample) |
| AU (1) | AU2021251718A1 (enExample) |
| CA (1) | CA3174985A1 (enExample) |
| IL (1) | IL297178A (enExample) |
| WO (1) | WO2021207136A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20250091839A (ko) | 2023-12-14 | 2025-06-23 | 김현우 | 강판의 부식방지용 페인트 자동 제거장치 |
| AU2025212118A1 (en) * | 2024-01-26 | 2026-07-16 | Cystic Fibrosis Foundation | Cftr super exon constructs and uses thereof |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1094974C (zh) * | 1998-12-31 | 2002-11-27 | 上海华晨生物技术研究所 | 表达人白细胞介素12的重组腺病毒及其制法和用途 |
| US7553494B2 (en) * | 2001-08-24 | 2009-06-30 | Corixa Corporation | WT1 fusion proteins |
| US20040142893A1 (en) * | 2002-10-21 | 2004-07-22 | Uichi Ikeda | Methods for treating and preventing vascular disease |
| US7026164B2 (en) * | 2003-07-03 | 2006-04-11 | Cell Genesys, Inc. | Adenovirus packaging cell lines |
| ES2391975T3 (es) * | 2003-07-25 | 2012-12-03 | Genvec, Inc. | Vacunas a base de vector adenovírico |
| WO2005110492A2 (en) * | 2004-04-12 | 2005-11-24 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Method of using adenoviral vectors to induce an immune response |
| WO2006065827A2 (en) * | 2004-12-13 | 2006-06-22 | Canji, Inc. | Cell lines for production of replication-defective adenovirus |
| WO2007134325A2 (en) * | 2006-05-15 | 2007-11-22 | Introgen Therapeutics, Inc. | Methods and compositions for protein production using adenoviral vectors |
| CN103966263A (zh) * | 2013-02-04 | 2014-08-06 | 广州医学院第一附属医院 | 一种重组人3型腺病毒及其制备方法和应用 |
| US9624510B2 (en) | 2013-03-01 | 2017-04-18 | The Wistar Institute | Adenoviral vectors comprising partial deletions of E3 |
| GB201620968D0 (en) * | 2016-12-09 | 2017-01-25 | Glaxosmithkline Biologicals Sa | Adenovirus polynucleotides and polypeptides |
| US10738282B2 (en) * | 2016-12-20 | 2020-08-11 | Salk Institute For Biological Studies | Use of phospholipid scramblase inhibitors for modulating inflammatory immune responses |
| MX2020003095A (es) * | 2017-09-22 | 2020-10-15 | Genzyme Corp | Arni variante. |
| BR112020019942A2 (pt) * | 2018-04-09 | 2021-01-26 | Salk Institute For Biological Studies | composições de adenovírus oncolítico com propriedades de replicação aprimoradas |
-
2021
- 2021-04-06 EP EP21721343.8A patent/EP4133090A1/en active Pending
- 2021-04-06 US US17/223,785 patent/US12227754B2/en active Active
- 2021-04-06 CN CN202610105012.3A patent/CN122104807A/zh active Pending
- 2021-04-06 WO PCT/US2021/025890 patent/WO2021207136A1/en not_active Ceased
- 2021-04-06 KR KR1020227038222A patent/KR20230008069A/ko active Pending
- 2021-04-06 CA CA3174985A patent/CA3174985A1/en active Pending
- 2021-04-06 CN CN202180040972.1A patent/CN115916984A/zh active Pending
- 2021-04-06 AU AU2021251718A patent/AU2021251718A1/en active Pending
- 2021-04-06 JP JP2022561644A patent/JP7750858B2/ja active Active
- 2021-04-06 IL IL297178A patent/IL297178A/en unknown
-
2025
- 2025-01-08 US US19/013,469 patent/US20250137013A1/en active Pending
- 2025-09-25 JP JP2025159003A patent/JP2025175172A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7832262B2 (ja) | 肝特異的ウイルスプロモーター及びその使用方法 | |
| JP2023509964A5 (enExample) | ||
| US12084654B2 (en) | Methods for using transcription-dependent directed evolution of AAV capsids | |
| JP2005501557A5 (enExample) | ||
| JP2008518591A5 (enExample) | ||
| JPH07509616A (ja) | 欠陥アデノウイルスおよび対応補足系 | |
| JP2024511621A5 (enExample) | ||
| JP2007500017A5 (enExample) | ||
| WO2022225978A1 (en) | Use of a split dcas fusion protein system for epigenetic editing | |
| CN113614231A (zh) | CAS12a向导RNA分子及其用途 | |
| CN116426573A (zh) | 重编程因子抗衰老表达系统、生物材料及用途 | |
| WO2024107985A2 (en) | Adenoviral helper plasmid | |
| CN111447954A (zh) | 用于恢复hbb基因功能的腺相关病毒组合物及其使用方法 | |
| JP7736329B2 (ja) | Ｄｕｘ４遺伝子を標的とした顔面肩甲上腕型筋ジストロフィーの治療方法 | |
| JPH11506311A (ja) | 遺伝子治療用のアデノウイルスベクター | |
| US20250019667A1 (en) | Adenoviral helper plasmid | |
| US7226779B2 (en) | Hybrid adenoviral vector | |
| WO2021230385A1 (en) | Method for treating muscular dystrophy by targeting utrophin gene | |
| CN115916984A (zh) | 腺病毒表达载体及生产方法和细胞系 | |
| JP2003507014A (ja) | コクサッキーウイルス類由来の遺伝子導入ベクター系 | |
| US20250064986A1 (en) | Optimized polynucleotides for protein expression | |
| WO2022145495A1 (en) | Method for treating spinocerebellar ataxias (sca) by targeting atxn7 gene | |
| US20090061488A1 (en) | Method of synthesizing a target polynucleotide encoding a protein | |
| WO2023147558A2 (en) | Crispr methods for correcting bag3 gene mutations in vivo | |
| WO2023190935A1 (en) | Method for treating myopathies by targeting titin gene |